Published in Drug Des Devel Ther on October 03, 2015
Monoamine oxidase: from genes to behavior. Annu Rev Neurosci (1999) 3.48
cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci U S A (1988) 2.59
Moclobemide: therapeutic use and clinical studies. CNS Drug Rev (2003) 1.55
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol (2006) 1.44
The pH dependence of kinetic isotope effects in monoamine oxidase A indicates stabilization of the neutral amine in the enzyme-substrate complex. FEBS J (2008) 1.17
Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats. Am J Physiol Heart Circ Physiol (2002) 1.11
Monoamine oxidase inhibition for tobacco pharmacotherapy. Clin Pharmacol Ther (2007) 1.04
Age-related increases in brain monoamine oxidase B in living healthy human subjects. Neurobiol Aging (1997) 1.03
Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures. J Clin Psychiatry (2012) 0.98
On tyramine, food, beverages and the reversible MAO inhibitor moclobemide. J Neural Transm Suppl (1988) 0.97
Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. Pharmacol Ther (2014) 0.95
Monoamine oxidases as sources of oxidants in the heart. J Mol Cell Cardiol (2014) 0.94
Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review). Mol Med Rep (2014) 0.84
Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. J Clin Psychiatry (2012) 0.84
Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implications. Curr Pharm Des (2014) 0.84
Selective inhibitors of monoamine oxidase type B and the "cheese effect". Int Rev Neurobiol (2011) 0.83
Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects. Clin Pharmacol Ther (1992) 0.82
Monoamine oxidases: the biochemistry of the proteins as targets in medicinal chemistry and drug discovery. Curr Top Med Chem (2012) 0.82
Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening. Bioorg Med Chem (2005) 0.81
Selegiline transdermal system: in the treatment of major depressive disorder. Drugs (2007) 0.79
α-Tetralone derivatives as inhibitors of monoamine oxidase. Bioorg Med Chem Lett (2014) 0.79
The inhibition of monoamine oxidase by esomeprazole. Drug Res (Stuttg) (2013) 0.79
Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues. Bioorg Med Chem (2010) 0.79
Indanones as high-potency reversible inhibitors of monoamine oxidase. ChemMedChem (2015) 0.79
Inhibitor design for monoamine oxidases. Curr Pharm Des (2013) 0.78
The Synthesis and Evaluation of C7-Substituted α-Tetralone Derivatives as Inhibitors of Monoamine Oxidase. Chem Biol Drug Des (2015) 0.77
2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors. Drug Des Devel Ther (2015) 0.75
Evaluation of 2-benzylidene-1-tetralone derivatives as antagonists of A1 and A2A adenosine receptors. Chem Biol Drug Des (2017) 0.75
Chalcone-inspired rA /A adenosine receptor ligands: Ring closure as an alternative to a reactive substructure. Chem Biol Drug Des (2021) 0.75
Inhibition of monoamine oxidase by selected phenylalkylcaffeine analogues. J Pharm Pharmacol (2013) 0.75